Table 4 Concomitant medications
Total (N = 41) n (%) | |
|---|---|
Number of patients with any concomitant medication | 40 (97.56) |
WHO ATC 2nd level/preferred term | |
Anti-Parkinson drugs | 1 (2.44) |
Anticholinergic agents | 1 (2.44) |
Antiepileptics | 4 (9.76) |
Antiepileptics | 1 (2.44) |
Gabapentin | 2 (4.88) |
Topiramate | 2 (4.88) |
Antihistamines for systemic use | 1 (2.44) |
Antihistamines | 1 (2.44) |
Psychoanaleptics | 19 (46.34) |
Antidepressants | 19 (46.34) |
Psycholeptics | 37 (90.24) |
Anxiolytics | 10 (24.39) |
Aripiprazole | 4 (9.76) |
Benzodiazepine derivatives | 17 (41.46) |
Brexpiprazole | 3 (7.32) |
Cariprazine | 1 (2.44) |
Clotiapine | 2 (4.88) |
Clozapine | 7 (17.07) |
Haloperidol | 4 (9.76) |
Olanzapine | 7 (17.07) |
Paliperidone | 1 (2.44) |
Pipamperone | 1 (2.44) |
Psychotropic agents | 24 (58.54) |
Quetiapine | 9 (21.95) |
Risperidone | 6 (14.63) |